Chondrogenic differentiation of amniotic fluid-derived stem cells

Yash M. Kolambkar, Alexandra Peister, Shay Soker, Anthony Atala, Robert E. Guldberg

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

For regenerating damaged articular cartilage, it is necessary to identify an appropriate cell source that is easily accessible, can be expanded to large numbers, and has chondrogenic potential. Amniotic fluid-derived stem (AFS) cells have recently been isolated from human and rodent amniotic fluid and shown to be highly proliferative and broadly pluripotent. The purpose of this study was to investigate the chondrogenic potential of human AFS cells in pellet and alginate hydrogel cultures. Human AFS cells were expanded in various media conditions, and cultured for three weeks with growth factor supplementation. There was increased production of sulfated glycosaminoglycan (sGAG) and type II collagen in response to transforming growth factor-β (TGF-β) supplementation, with TGF-β1 producing greater increases than TGF-β3. Modification of expansion media supplements and addition of insulin-like growth factor-1 during pellet culture further increased sGAG/DNA over TGF-β1 supplementation alone. Compared to bone marrow-derived mesenchymal stem cells, the AFS cells produced less cartilaginous matrix after three weeks of TGF-β1 supplementation in pellet culture. Even so, this study demonstrates that AFS cells have the potential to differentiate along the chondrogenic lineage, thus establishing the feasibility of using these cells for cartilage repair applications.

Original languageEnglish
Pages (from-to)405-413
Number of pages9
JournalJournal of Molecular Histology
Volume38
Issue number5
DOIs
StatePublished - Oct 1 2007
Externally publishedYes

Fingerprint

Amniotic Fluid
Transforming Growth Factors
Stem Cells
A73025
Collagen Type II
Hydrogel
Articular Cartilage
Somatomedins
Mesenchymal Stromal Cells
Cartilage
Rodentia
Intercellular Signaling Peptides and Proteins
Bone Marrow
DNA

Keywords

  • Amniotic fluid stem cells
  • Cartilage repair
  • Chondrogenic differentiation
  • Mesenchymal stem cells
  • Pellet culture
  • Transforming growth factor-beta

ASJC Scopus subject areas

  • Cell Biology
  • Anatomy

Cite this

Kolambkar, Y. M., Peister, A., Soker, S., Atala, A., & Guldberg, R. E. (2007). Chondrogenic differentiation of amniotic fluid-derived stem cells. Journal of Molecular Histology, 38(5), 405-413. https://doi.org/10.1007/s10735-007-9118-1

Chondrogenic differentiation of amniotic fluid-derived stem cells. / Kolambkar, Yash M.; Peister, Alexandra; Soker, Shay; Atala, Anthony; Guldberg, Robert E.

In: Journal of Molecular Histology, Vol. 38, No. 5, 01.10.2007, p. 405-413.

Research output: Contribution to journalArticle

Kolambkar, YM, Peister, A, Soker, S, Atala, A & Guldberg, RE 2007, 'Chondrogenic differentiation of amniotic fluid-derived stem cells', Journal of Molecular Histology, vol. 38, no. 5, pp. 405-413. https://doi.org/10.1007/s10735-007-9118-1
Kolambkar, Yash M. ; Peister, Alexandra ; Soker, Shay ; Atala, Anthony ; Guldberg, Robert E. / Chondrogenic differentiation of amniotic fluid-derived stem cells. In: Journal of Molecular Histology. 2007 ; Vol. 38, No. 5. pp. 405-413.
@article{66d9653319e741a1a984a421a6d54558,
title = "Chondrogenic differentiation of amniotic fluid-derived stem cells",
abstract = "For regenerating damaged articular cartilage, it is necessary to identify an appropriate cell source that is easily accessible, can be expanded to large numbers, and has chondrogenic potential. Amniotic fluid-derived stem (AFS) cells have recently been isolated from human and rodent amniotic fluid and shown to be highly proliferative and broadly pluripotent. The purpose of this study was to investigate the chondrogenic potential of human AFS cells in pellet and alginate hydrogel cultures. Human AFS cells were expanded in various media conditions, and cultured for three weeks with growth factor supplementation. There was increased production of sulfated glycosaminoglycan (sGAG) and type II collagen in response to transforming growth factor-β (TGF-β) supplementation, with TGF-β1 producing greater increases than TGF-β3. Modification of expansion media supplements and addition of insulin-like growth factor-1 during pellet culture further increased sGAG/DNA over TGF-β1 supplementation alone. Compared to bone marrow-derived mesenchymal stem cells, the AFS cells produced less cartilaginous matrix after three weeks of TGF-β1 supplementation in pellet culture. Even so, this study demonstrates that AFS cells have the potential to differentiate along the chondrogenic lineage, thus establishing the feasibility of using these cells for cartilage repair applications.",
keywords = "Amniotic fluid stem cells, Cartilage repair, Chondrogenic differentiation, Mesenchymal stem cells, Pellet culture, Transforming growth factor-beta",
author = "Kolambkar, {Yash M.} and Alexandra Peister and Shay Soker and Anthony Atala and Guldberg, {Robert E.}",
year = "2007",
month = "10",
day = "1",
doi = "10.1007/s10735-007-9118-1",
language = "English",
volume = "38",
pages = "405--413",
journal = "Journal of Molecular Histology",
issn = "1567-2379",
publisher = "Springer Netherlands",
number = "5",

}

TY - JOUR

T1 - Chondrogenic differentiation of amniotic fluid-derived stem cells

AU - Kolambkar, Yash M.

AU - Peister, Alexandra

AU - Soker, Shay

AU - Atala, Anthony

AU - Guldberg, Robert E.

PY - 2007/10/1

Y1 - 2007/10/1

N2 - For regenerating damaged articular cartilage, it is necessary to identify an appropriate cell source that is easily accessible, can be expanded to large numbers, and has chondrogenic potential. Amniotic fluid-derived stem (AFS) cells have recently been isolated from human and rodent amniotic fluid and shown to be highly proliferative and broadly pluripotent. The purpose of this study was to investigate the chondrogenic potential of human AFS cells in pellet and alginate hydrogel cultures. Human AFS cells were expanded in various media conditions, and cultured for three weeks with growth factor supplementation. There was increased production of sulfated glycosaminoglycan (sGAG) and type II collagen in response to transforming growth factor-β (TGF-β) supplementation, with TGF-β1 producing greater increases than TGF-β3. Modification of expansion media supplements and addition of insulin-like growth factor-1 during pellet culture further increased sGAG/DNA over TGF-β1 supplementation alone. Compared to bone marrow-derived mesenchymal stem cells, the AFS cells produced less cartilaginous matrix after three weeks of TGF-β1 supplementation in pellet culture. Even so, this study demonstrates that AFS cells have the potential to differentiate along the chondrogenic lineage, thus establishing the feasibility of using these cells for cartilage repair applications.

AB - For regenerating damaged articular cartilage, it is necessary to identify an appropriate cell source that is easily accessible, can be expanded to large numbers, and has chondrogenic potential. Amniotic fluid-derived stem (AFS) cells have recently been isolated from human and rodent amniotic fluid and shown to be highly proliferative and broadly pluripotent. The purpose of this study was to investigate the chondrogenic potential of human AFS cells in pellet and alginate hydrogel cultures. Human AFS cells were expanded in various media conditions, and cultured for three weeks with growth factor supplementation. There was increased production of sulfated glycosaminoglycan (sGAG) and type II collagen in response to transforming growth factor-β (TGF-β) supplementation, with TGF-β1 producing greater increases than TGF-β3. Modification of expansion media supplements and addition of insulin-like growth factor-1 during pellet culture further increased sGAG/DNA over TGF-β1 supplementation alone. Compared to bone marrow-derived mesenchymal stem cells, the AFS cells produced less cartilaginous matrix after three weeks of TGF-β1 supplementation in pellet culture. Even so, this study demonstrates that AFS cells have the potential to differentiate along the chondrogenic lineage, thus establishing the feasibility of using these cells for cartilage repair applications.

KW - Amniotic fluid stem cells

KW - Cartilage repair

KW - Chondrogenic differentiation

KW - Mesenchymal stem cells

KW - Pellet culture

KW - Transforming growth factor-beta

UR - http://www.scopus.com/inward/record.url?scp=35848964804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35848964804&partnerID=8YFLogxK

U2 - 10.1007/s10735-007-9118-1

DO - 10.1007/s10735-007-9118-1

M3 - Article

C2 - 17668282

AN - SCOPUS:35848964804

VL - 38

SP - 405

EP - 413

JO - Journal of Molecular Histology

JF - Journal of Molecular Histology

SN - 1567-2379

IS - 5

ER -